Sheinbaum Reaffirms Mexico’s Sovereignty Amidst Trump’s Military Intervention Threats; Nvidia Forges $1 Billion AI Drug Discovery Alliance with Lilly
Stock Market News·2026-01-12 15:38

Group 1: Mexico-U.S. Relations - Mexican President Claudia Sheinbaum firmly rejected any U.S. military intervention in Mexico, emphasizing national sovereignty and the country's ability to handle its own security issues [2][3] - Sheinbaum announced a 50% decrease in fentanyl trafficking from Mexico to the U.S. over the past year, attributing this success to Mexico's anti-drug operations and increased fentanyl seizures [3][7] - A U.S.-Mexico security committee meeting is scheduled for January 22-23, indicating ongoing dialogue between the two nations regarding security cooperation [3][7] Group 2: Nvidia's Investments in Life Sciences - Nvidia is investing up to $1 billion over five years to establish a co-innovation AI lab with Eli Lilly, aimed at reinventing drug discovery through AI applications [4][7] - The collaboration with Thermo Fisher Scientific focuses on developing autonomous lab infrastructure to enhance scientific discovery, with Nvidia's BioNeMo platform being widely adopted in the life sciences sector [5][7] - New AI models for RNA structure prediction and drug synthesis validation are part of Nvidia's expansion in the life sciences, aiming to turn scientific data into a competitive advantage [5][7] Group 3: European Financial Markets - ABN AMRO successfully priced a EUR1.75 billion debt offering, structured in two parts: a EUR1 billion 3-year fixed tranche and a EUR750 million 10-year fixed tranche [6][7] - The Bank of England sold GBP800 million in gilts, achieving a cover-ratio of 3.19, indicating strong demand for government bonds [8][7]